Search for: "Johnson v. Director of DOC"
Results 41 - 46
of 46
Sort by Relevance
|
Sort by Date
30 May 2008, 9:09 am
– Brdo: (IPR-Helpdesk), 5-6 June: USFDA public meeting on evaluation of product trade names: (FDA Law Blog), 5-7 June: European research and innovation exhibition – Paris: (IPR-Helpdesk), 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First… [read post]
16 May 2008, 8:03 am
, (IPRoo), StemCells files second patent lawsuit against Neuralstem in relation to human neural stem cells: (IPBiz), (IP Law360), (Patent Docs), (California Biotech Law Blog), Patent Reform Act removed from Senate calendar: (Peter Zura's 271 Patent Blog), (IAM), (Managing Intellectual Property), (IP Law360), Global Global - General New WIPO Director General: Francis Gurry of Australia: (WIPO), (Managing Intellectual Property), (Innovationpartners), (IAM),… [read post]
9 May 2008, 10:30 pm
, US: ACI ‘In-house counsel forum on pharmaceutical antitrust’ – 20-21 May, Maryland: (Orange Book Blog), EU: Workshop for mediators in IP disputes – 26-27 May, Geneva: (IPR-Helpdesk), US: PLI: ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – 28 May, New York / 11 June, San Francisco: (Patent Docs), US: Worldwide Business Research: PharmaBiotech IP summit –… [read post]
18 Apr 2008, 2:00 am
, (IMPACT), USPTO launches First Action Interview Pilot Program: (IP Law360), (Peter Zura's 271 Patent Blog), (Patent Baristas), (Patently-O), (Patent Docs), (IP Spotlight), (Anticipate This!) [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007:… [read post]
